Race Oncology activates second site for solid tumour clinical trial
Race Oncology opened patient enrolment at a second site for its Phase 1 clinical trial of RC220 in patients with advanced solid tumours, the company announced on Tuesday. The Central Coast Local Health District, comprising Gosford and Wyong Hospitals, has been activated following the earlier activation of the lead Australian site, Southside Cancer Centre in…